COMMUNIQUÉS West-GlobeNewswire

Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate Update

07/11/2017 - 13:30

WATERTOWN, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted [...]

Spark Therapeutics Reports Third Quarter 2017 Financial Results and Recent Business Progress

07/11/2017 - 13:30

PHILADELPHIA, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today financial [...]

Strongbridge Biopharma plc to Present at the Stifel 2017 Healthcare Conference

07/11/2017 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Zynerba Pharmaceuticals to Present at Upcoming Investor Conferences

07/11/2017 - 13:30

DEVON, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically- [...]

Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands

07/11/2017 - 13:30

Waltham, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands [...]

Geron Announces November Investor Conference Presentation Webcasts

07/11/2017 - 13:30

MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the following investor [...]

Conatus to Present at Stifel Healthcare Conference

07/11/2017 - 13:30

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced its scheduled presentation to provide an overview of the company’s programs and outlook at the Stifel 2017 [...]

Spark Therapeutics and Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B

07/11/2017 - 13:15

Spark Therapeutics to receive up to an additional $25 million per terms of amendment

ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis

07/11/2017 - 13:01

G eneva, Switzerland and Boston, MA - November 7, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

U.S. FDA Approves Auryxia® (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis

07/11/2017 - 13:01

BOSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a company focused on bringing innovative medicines to people with kidney disease, today announced that the U.S. Food and Drug [...]

Vericel Reports Third-Quarter 2017 Financial Results

07/11/2017 - 13:00

Record Third Quarter Revenue of $14.3 Million Represents a 30% Increase Over Third Quarter 2016

AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017

07/11/2017 - 13:00

ALACHUA, Fla., Nov. 07, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, today announced that it [...]

Keryx Biopharmaceuticals Announces Third Quarter 2017 Financial Results

07/11/2017 - 13:00

BOSTON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced its financial [...]

Aclaris Therapeutics Reports Third Quarter 2017 Financial Results

07/11/2017 - 13:00

Management to Host Conference Call at 8:00 AM ET today

Targovax ASA: Notice of Extraordinary General Meeting

07/11/2017 - 11:39

An Extraordinary General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 30 November 2017 at 13:00 CET. Please find the notice including agenda for the Extraordinary General Meeting and [...]

Verona Pharma Reports Patient Enrollment Progressing Ahead of Schedule in Ongoing Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment

07/11/2017 - 08:00

Top-line data from the study now expected in mid-2018 LONDON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on [...]

Verona Pharma plc Operational Update and Financial Results for the Third Quarter Ended September 30, 2017

07/11/2017 - 08:00

Emerging clinical data confirms the potential for RPL554 to be an important, novel treatment for patients with COPD LONDON, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma" or [...]

Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation

07/11/2017 - 07:30

ORION CORPORATION PRESS RELEASE 7 NOVEMBER 2017 at 8.30 EET Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation Professor Heikki Joensuu, M.D., Ph.D., has [...]

Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage

07/11/2017 - 07:15

Structural joint damage in psoriatic arthritis (PsA) patients taking Cosentyx ® (secukinumab) was inhibited at 24 weeks versus placebo in all arms of the study[1] PsA can lead to reduced mobility and irreversible joint [...]